Mulberry leaf extract reduces postprandial hyperglycemia with few side effects by inhibiting α-glucosidase in normal rats

Journal of Medicinal Food

Volumn 14, Issue 7-8, 2011, Pages 712-717

  Kim, Gyo Nam ^a   Kwon, Young In ^a   Jang, Hae Dong ^a  

^a Hannam University   (South Korea)

Author keywords

a glucosidase inhibitory activity; feeding test; mulberry leaf extract; reduced side effects; sugar loading test

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; AMYLASE; GLUCOSE; MALTOSE; MULBERRY EXTRACT; STARCH; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; AUTOCLAVE; CARBOHYDRATE METABOLISM; CECUM; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG SYNTHESIS; ENZYME INHIBITION; FECES COLOR; FLATULENCE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; METEORISM; NONHUMAN; ORGAN SIZE; ORGAN WEIGHT; POSTPRANDIAL HYPERGLYCEMIA; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; TIME TO MAXIMUM PLASMA CONCENTRATION;

ALPHA-GLUCOSIDASES; ANIMALS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENZYME INHIBITORS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INTESTINES; MALE; MORUS; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR;

MORUS (ANGIOSPERM); MORUS ALBA; RATTUS;

EID: 79960440902     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2010.1368     Document Type: Article

References (23)

1. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes. Diabetes Care 2004;27:1047-1053.
2. Harris M: Epidemiology and scope of the problem. Diabetes Care 1998;21(Suppl):C11-C14.
3. Horii S, Fukasse K, Matsuo T, Kameda K, Asano N, Masui Y: Synthesis and a-d-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potent oral antidiabetic agents. J Med Chem 2005;29:938-1046.
4. Harold E, Lebovitz MD: Alpha-glucosidase inhibitors. Endo-crinol Metab Clin 1997;26:539-551.
5. Brownlee M: The pathobiology of diabetic complications. Diabetes 2005;54:1615-1625.
6. Kaiser N, Sasson S, Feener EP, Boukobza N, Higashi S, Moller DE: Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 1993;42:80-89. (Pubitemid 23013798)
7. Puls W, Keup U, Krause HP, Thomas G, Hoffmeister R: Glu-cosidase inhibition. A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia. Naturwissenschafen 1977; 64:536-537. (Pubitemid 8197894)
8. Caspary WF: Sucrose malabsorption in man after ingestion of a-glucosidehydrolase inhibitor. Lancet 1978;1:1231-1233. (Pubitemid 8362420)
9. Caspary WF, Graf S: Inhibition of human intestinal a-glucosi-dehydrolase by a new complex oligosaccharide. Res Exp Med 1979;175:1-6. (Pubitemid 9214738)
10. Chiasson JL, Josse RG, Gomis R: Acarbose for prevention of type 2 diabetes mellitus: the STPO-NIDDM randomised trial. Lancet 2002;359:2072-2077. (Pubitemid 34680970)
11. Dehghan-Kooshkghazi M, Mathers JC: Starch digestion, large-bowel fermentation and intestinal mucosal cell proliferation in rats treated with the a-glucosidase inhibitor acarbose. Br J Nutr 2004;91:357-365. (Pubitemid 38386899)
12. Liu LK, Chou FP, Chen YC, Ho HH, Wang CJ: Effects of mulberry (Morus alba L.) extracts on lipid homeostasis in vitro and in vivo. J Agric Food Chem 2009;57:7605-7611.
13. Naowaboot J, Pannangpetch P, Kukonqviriyapan V, Kongyin-gyoes B, Kukonqviriyapan U: Antihyperglycemic, antioxidant and antiglycation activities of mulberry leaf extract in strepto-zotocin-induced chronic diabetic rats. Plant Foods Hum Nutr 2009;64:116-121.
14. Jang MJ, Rhee SJ: Hypoglycemic effects of pills made of mulberry leaves and silkworm powder in streptozotocin-induced diabetic rats. J Korean Soc Food Sci Nutr 2004;33:1611-1617.
15. Kim SY, Ryu KS, Lee WC, Ku HO, Lee HS, Lee KR: Hypo-glycemic effect of mulberry leaves with anaerobic treatment in alloxan-induced diabetic mice. Korean J Pharmacogn 1999;30: 123-129.
16. Miyahara C, Miyazawa M, Satoh S, Sakai A, Mizusaki S: Inhibitory effects of mulberry leaf extract on postprandial hyper-glycemia in normal rats. J Nutr Sci Vitaminol 2004;50:161-164. (Pubitemid 39045117)
17. Kwon YI, Vattem DA, Shetty K: Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia Pac J Clin Nutr 2006;15:107-118. (Pubitemid 43341846)
18. Ohta T, Sasaki S, Oohori T, Yoshikawa S, Kurihara H: a-Glucosidase inhibitory activity of a 70% methanol extract from Ezoishige (Pelvetia babingtonii de Toni) and its effect on the elevation of blood glucose level in rats. Biosci Biotechnol Bio-chem 2002;66:1552-1554. (Pubitemid 39246862)
19. Chae JY, Lee JY, Hoang IS, Whangbo D, Choi PW, Lee WC, Kim JW, Kim SY, Choi SW, Rhee SJ: Analysis of functional components of leaves of different mulberry cultivars. J Korean Soc Food Sci Nutr 2003;32:15-21. (Pubitemid 36385865)
20. Kim SY, Lee WC, Kim HB, Kim AJ, Kim SK: Antihyperlipi-demic effects of methanol extracts from mulberry leaves in cholesterol-induced hyperlipidemia rats. J Korean Soc Food Sci Nutr 1998;27:1217-1222.
21. Bang HS, Lee WC, Shon HR, Choi YC, Kim HB: Varietal comparison of c-aminobutyric acid content in mulberry root bark. Korean J Seric Sci 1998;40:13-16.
22. Yun SJ, Lee WC: Studies on the utilization of pharmacologically active constituents in mulberry: 1. Varietal and seasonal variations of flavonol glycoside content in leaves. RDA J Agric Sci 1995;37:201-205.
23. GaoH,KawabataJ:a-Glucosidase inhibitionof 6-hydroxyflavones. Part 3: Synthesis and evaluation of 2,3,4-trihydroxybenzoyl-containing flavonoid analogs and 6-aminoflavones as a-glucosidase inhibitors. Bioorg Med Chem 2005;13:1661-1671.